At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 4:36:59 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BARNETT EVA RENEE Chief Financial Officer | Sale | Nov 20, 2024 | 331,169 |
GEFFNER MICHAEL Officer | Sale | Oct 23, 2024 | 134,971 |
GLORIA MELANIE Chief Operating Officer | Stock Award(Grant) | Nov 18, 2024 | 109,956 |
HUGHES DOUGLAS J Director | Sale | Dec 2, 2024 | 119,585 |
LEVINE MARK S Officer | Sale | Nov 20, 2024 | 319,228 |
MACIAS WILLIAM L Officer | Sale | Nov 20, 2024 | 361,791 |
PANDE ATUL Director | Sale | Dec 2, 2024 | 106,663 |
SALZMANN PETER Chief Executive Officer | Sale | Nov 20, 2024 | 978,097 |
STOUT JAY S Chief Technology Officer | Sale | Oct 23, 2024 | 142,186 |
VAN TUYL CHRISTOPHER Officer | Stock Award(Grant) | Dec 16, 2024 | 109,956 |
Related Tickers
BHVN Biohaven Ltd.
36.26
+2.60%
CYTK Cytokinetics, Incorporated
48.87
+4.56%
ROIV Roivant Sciences Ltd.
11.57
+0.61%
MLTX MoonLake Immunotherapeutics
52.17
+0.56%
ARGX argenx SE
623.82
-0.35%
VRDN Viridian Therapeutics, Inc.
19.03
+1.60%
APGE Apogee Therapeutics, Inc.
47.71
+1.47%
AGIO Agios Pharmaceuticals, Inc.
35.42
-1.09%
BBIO BridgeBio Pharma, Inc.
26.49
+1.07%
NUVL Nuvalent, Inc.
84.22
-0.50%